More than a million vaccinated European citizens will not be able to travel to the US even after November 8!
From November 8, The US will allow travel for tourism purposes for citizens of 33 countries around the world, including the 26 in the Schengen area and the European Union, but also Ireland and the United Kingdom. But there will be at least one million European Union citizens, most of them from Hungary, who will not be able to travel to the United States even after November 8.
Revealing more details about removing the entry ban for vaccinated travelers, the White House said those eligible to enter the U.S. will be those who have been vaccinated with one of the vaccines approved by the U.S. Federal Drug Administration (FDA) and the World Health Organization. Health (WHO).
But so far neither organization has approved the Russian vaccine against COVID-19 - Sputnik V. Data from the European Center for Disease Prevention and Control (ECDC) show that two EU member states, Hungary and Slovakia, have administered the Sputnik V vaccine.
About one million people in Hungary will not be able to travel to the United States
To date, Hungary has administered 1 doses of Sputnik V out of two million purchased, and Slovakia has administered 806 out of 156 doses purchased. Given that Sputnik V is a two-dose vaccine, this means that approximately 37677 Hungarians and 200 Slovaks have been vaccinated with Sputnik V. No other EU country or Schengen country has administered the Sputnik vaccine on its territory. .
However, there are regions and countries outside the EU that have administered the Sputnik V vaccine, with San Marino being one of them. The European microstat has vaccinated over 70% of its adult population with the Russian vaccine against COVID-19, which is also the only vaccine administered in this country, which hosts about 33 citizens. However, according to some reports, the Russian vaccine was also administered to the Italians. No less than 15 people on the peninsula, especially those working in San Marino, have been inoculated with this vaccine.
The European Medicines Agency (EMA) has not yet approved the vaccine either, although it began reviewing it on March 4, 2021. Moreover, it has recently been reported that the agency has postponed approval of the vaccine for the first quarter of 2022. The decision was made after the manufacturer did not provide the necessary data for the planned review which was to take place by the end of November.